Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis

Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular... Surg Today (2018) 48:73–79 https://doi.org/10.1007/s00595-017-1553-3 ORIGINAL ARTICLE Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi‑center analysis 1 1 1 2 3 4 Hiroshi Wada · Hidetoshi Eguchi · Hiroaki Nagano · Shoji Kubo · Takuya Nakai · Masaki Kaibori · 5 2 2 3 4 Michihiro Hayashi · Shigekazu Takemura · Shogo Tanaka · Yasuyuki Nakata · Kosuke Matsui · 4 5 5 5 4 Morihiko Ishizaki · Fumitoshi Hirokawa · Koji Komeda · Kazuhisa Uchiyama · Masanori Kon · 1 1 Yuichiro Doki · Masaki Mori Received: 18 March 2017 / Accepted: 22 May 2017 / Published online: 8 June 2017 © Springer Japan KK 2017 Abstract lower in the AT group than in the non-AT group in uni- Purpose The influence of allogenic blood transfusion on variate (P < 0.001) and multivariate analyses (risk ratio the postoperative outcomes of hepatocellular carcinoma 1.521, P = 0.011). After matching the different distribu- (HCC) surgery remains controversial. This study aims to tions using propensity scores, perioperative blood transfu- clarify the clinical impacts of perioperative allogenic blood sion was found to be a poor prognostic factor for HCC transfusion on liver resection outcome in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Surgery Today Springer Journals
Loading next page...
 
/lp/springer_journal/perioperative-allogenic-blood-transfusion-is-a-poor-prognostic-factor-qnHRJg0Ufp
Publisher
Springer Japan
Copyright
Copyright © 2017 by Springer Japan KK
Subject
Medicine & Public Health; Surgery; Surgical Oncology
ISSN
0941-1291
eISSN
1436-2813
D.O.I.
10.1007/s00595-017-1553-3
Publisher site
See Article on Publisher Site

Abstract

Surg Today (2018) 48:73–79 https://doi.org/10.1007/s00595-017-1553-3 ORIGINAL ARTICLE Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi‑center analysis 1 1 1 2 3 4 Hiroshi Wada · Hidetoshi Eguchi · Hiroaki Nagano · Shoji Kubo · Takuya Nakai · Masaki Kaibori · 5 2 2 3 4 Michihiro Hayashi · Shigekazu Takemura · Shogo Tanaka · Yasuyuki Nakata · Kosuke Matsui · 4 5 5 5 4 Morihiko Ishizaki · Fumitoshi Hirokawa · Koji Komeda · Kazuhisa Uchiyama · Masanori Kon · 1 1 Yuichiro Doki · Masaki Mori Received: 18 March 2017 / Accepted: 22 May 2017 / Published online: 8 June 2017 © Springer Japan KK 2017 Abstract lower in the AT group than in the non-AT group in uni- Purpose The influence of allogenic blood transfusion on variate (P < 0.001) and multivariate analyses (risk ratio the postoperative outcomes of hepatocellular carcinoma 1.521, P = 0.011). After matching the different distribu- (HCC) surgery remains controversial. This study aims to tions using propensity scores, perioperative blood transfu- clarify the clinical impacts of perioperative allogenic blood sion was found to be a poor prognostic factor for HCC transfusion on liver resection outcome in

Journal

Surgery TodaySpringer Journals

Published: Jun 8, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off